Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Galli
Michele Moretti

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
European Journal of Radiology|March 4, 2021
Prognostic value of CT integrated with clinical and laboratory data during the first peak of the COVID-19 pandemic in Northern Italy: A nomogram to predict unfavorable outcomeEnzo Angeli, Serena Dalto, Stefano Marchese, et al.
Clinical and Experimental Rheumatology|April 3, 2026
Systemic vasculitis: one year in review 2026Chiara Marvisi, Paolo Delvino, Federica Di Cianni, et al.
Clinical and Experimental Rheumatology|April 19, 2023
Systemic vasculitis: one year in review 2023Michele Moretti, Elena Treppo, Sara Monti, et al.
Cells|March 6, 2021
Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma PatientsFrancesco De Logu, Francesca Galli, Romina Nassini, et al.
British Journal of Cancer|August 19, 2016
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancerRobert Fruscio, Lorenzo Ceppi, Silvia Corso, et al.
Clinical Lung Cancer|August 8, 2025
Rationale and Design of the AUSTRAL trial: An Open-Label, Multicenter, Phase II Study Evaluating Radiotherapy Followed by Durvalumab (MEDI4736) and Ceralasertib (AZD6738) in Stage III NSCLC Patients With Thoracic Relapses and/or Oligometastases After the PACIFIC RegimenAndrea Riccardo Filippi, Eliana Rulli, Diego Signorelli, et al.
Clinical and Experimental Rheumatology|April 29, 2024
Systemic vasculitis: one year in review 2024Elena Treppo, Sara Monti, Paolo Delvino, et al.
Journal of Geriatric Oncology|June 20, 2015
Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13)Andrea Luciani, Laura Biganzoli, Giuseppe Colloca, et al.
Gynecologic Oncology|December 23, 2018
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasmsLorenzo Ceppi, Francesca Galli, Maria Lamanna, et al.
Journal of the American Academy of Dermatology|November 19, 2018
Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thicknessSimone Ribero, Francesca Galli, Simona Osella-Abate, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
European Journal of Radiology|March 4, 2021
Prognostic value of CT integrated with clinical and laboratory data during the first peak of the COVID-19 pandemic in Northern Italy: A nomogram to predict unfavorable outcomeEnzo Angeli, Serena Dalto, Stefano Marchese, et al.
Clinical and Experimental Rheumatology|April 3, 2026
Systemic vasculitis: one year in review 2026Chiara Marvisi, Paolo Delvino, Federica Di Cianni, et al.
Clinical and Experimental Rheumatology|April 19, 2023
Systemic vasculitis: one year in review 2023Michele Moretti, Elena Treppo, Sara Monti, et al.
Cells|March 6, 2021
Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma PatientsFrancesco De Logu, Francesca Galli, Romina Nassini, et al.
British Journal of Cancer|August 19, 2016
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancerRobert Fruscio, Lorenzo Ceppi, Silvia Corso, et al.
Clinical Lung Cancer|August 8, 2025
Rationale and Design of the AUSTRAL trial: An Open-Label, Multicenter, Phase II Study Evaluating Radiotherapy Followed by Durvalumab (MEDI4736) and Ceralasertib (AZD6738) in Stage III NSCLC Patients With Thoracic Relapses and/or Oligometastases After the PACIFIC RegimenAndrea Riccardo Filippi, Eliana Rulli, Diego Signorelli, et al.
Clinical and Experimental Rheumatology|April 29, 2024
Systemic vasculitis: one year in review 2024Elena Treppo, Sara Monti, Paolo Delvino, et al.
Journal of Geriatric Oncology|June 20, 2015
Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13)Andrea Luciani, Laura Biganzoli, Giuseppe Colloca, et al.
Gynecologic Oncology|December 23, 2018
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasmsLorenzo Ceppi, Francesca Galli, Maria Lamanna, et al.
Journal of the American Academy of Dermatology|November 19, 2018
Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thicknessSimone Ribero, Francesca Galli, Simona Osella-Abate, et al.
Pageof 10